Condition: Childhood Ependymoma · Sponsor: Centre Leon Berard
The overall aim of this project is to improve the outcome of patients diagnosed with ependymoma by improving and harmonising the staging and the standard of care of this patient population and to improve the investigators understanding of the underlying biology thereby informing future treatment. The program will evaluate new strategies for diagnosis (centralized reviews of pathology and imaging) and new therapeutic strategies in order to develop treatment recommendations. Patients will be stratified into different treatment subgroups according to their age, the tumour location and the outcome of the initial surgery. Each subgroup will be studied in a specific randomised study to evaluate the proposed therapeutic strategies. Stratum 1: The aim of the stratum 1 is to evaluate the clinical impact of 16-week chemotherapy regimen with VEC-CDDP following surgical resection and conformal radiotherapy in terms of progression free survival in patients who are \> 12 months and \< 22 years at diagnosis, with completely removed intra cranial Ependymoma. Stratum 2: This stratum is designed as a phase II trial for patients who are \> 12 months and \< 22 years at diagnosis, with residual disease to investigate the possible activity of HD-MTX by giving to all patients the benefit of VEC chemotherapy whilst randomising half of patients to receive additional HD-MTX. Patients will receive conformal radiotherapy (cRT). For patients who remain with a residual inoperable disease after indu…
This description comes directly from the study's public registry record.
Pierre LEBLOND, MD · +33 4 69 16 66 14 · pierre.leblond@lyon.unicancer.fr
Always discuss trial participation with your own doctor first.
| Medical University of Graz-Department of Pediatrics and Adolescent Medicine | Graz, Austria | Recruiting |
| CHR de la CITADELLE | Liège, Belgium | Recruiting |
| University Hospital Brno | Brno, Czechia | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| CHRU STRASBOURG - Hôpital de Hautepierre | Strasbourg, Bas-Rhin, France | Recruiting |
| AP-HM - Hôpital d'Enfants de La Timone | Marseille, Bouches-du-Rhône, France | Recruiting |
| CHU Dijon - Hôpital des Enfants | Dijon, Côte d'Or, France | Recruiting |
| CHRU BESANCON - Hôpital Jean Minjoz | Besançon, Doubs, France | Recruiting |
| CHRU BREST - Hôpital Morvan | Brest, Finistère, France | Recruiting |
| CHU de Bordeaux-Hôpital des enfants Pellegrin | Bordeaux, Gironde, France | Recruiting |
| CHU de TOULOUSE - Hôpital des Enfants | Toulouse, Haute-Garonne, France | Recruiting |
| CHRU MONTPELLIER - Hôpital Arnaud de Villeneuve | Montpellier, Herault, France | Recruiting |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02265770